Biotinylated anti-bacteria primary antibodies are specialized immunological reagents in which biotin, a low-molecular-weight vitamin, is covalently conjugated to antibodies that specifically recognize bacterial antigens. This modification enables ultrasensitive detection through the exceptionally strong interaction (Kd ≈ 10-15 M) between biotin and streptavidin, avidin, or neutravidin conjugates.
Basic Mechanism
Biotinylation is typically achieved by targeting primary amine groups on lysine residues using N-hydroxysuccinimide (NHS)-ester activated biotin. This results in the incorporation of approximately 3–6 biotin molecules per IgG without significantly affecting antigen-binding affinity. In downstream detection assays, biotinylated antibodies first bind to bacterial targets, followed by the addition of streptavidin conjugated to enzymes or fluorophores, enabling signal generation and amplification.
Key Applications
- ELISA and Immunoassays: Sandwich assay formats allow the detection of bacterial pathogens such as E. coli O157 or Salmonella with sensitivities typically in the range of 104–105 CFU/mL.
- Flow Cytometry: Enables rapid bacterial identification and quantification through fluorescent streptavidin labeling.
- Immunohistochemistry: Facilitates the localization of bacterial antigens in tissue sections using chromogenic or fluorescent detection systems.
- Magnetic Separation: Biotin-streptavidin coated microbeads are used to selectively enrich and isolate target bacteria from complex biological samples.
- Western Blotting: Allows detection of bacterial proteins following electrophoretic separation and membrane transfer.